Dr. Shirin Hooshmand, PhD
Claim this profileClinical Trials Shirin Hooshmand, PhD is currently running
More about Shirin Hooshmand, PhD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Shirin Hooshmand, PhD has experience with
- Prunes
Breakdown of trials Shirin Hooshmand, PhD has run
Osteopenia and Osteoporosis
Metabolic Bone Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shirin Hooshmand, PhD specialize in?
Shirin Hooshmand, PhD focuses on Osteopenia and Osteoporosis and Metabolic Bone Diseases. In particular, much of their work with Osteopenia and Osteoporosis has involved treating patients, or patients who are undergoing treatment.
Is Shirin Hooshmand, PhD currently recruiting for clinical trials?
Yes, Shirin Hooshmand, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Shirin Hooshmand, PhD has studied deeply?
Yes, Shirin Hooshmand, PhD has studied treatments such as Prunes.
What is the best way to schedule an appointment with Shirin Hooshmand, PhD?
Apply for one of the trials that Shirin Hooshmand, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.